The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2908296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Qiong Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, 210000 Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Transcription Factors, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of Nantong Municipal Health Commission.
Abstract (Originalsprache)
Background
Non-small cell lung cancer (NSCLC) is a malignant form of lung cancer, and its prognosis could be improved by identifying key therapeutic targets. Thus, this study investigates the potential role of F-box Only Protein 33 (FBXO33) in NSCLC.
Methods
The expression levels of FBXO33 in NSCLC were determined using University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN) prediction, and its correlation with overall survival (OS) was analyzed via Kaplan-Meier survival analysis. These results were validated through quantitative polymerase chain reaction (qPCR), western blot (WB), and immunofluorescence (IF). We modulated FBXO33 expression by overexpression or knockdown and analyzed its effects on cell growth, proliferation, migration, invasion, and stemness characteristics in NSCLC cell lines. Additionally, the interaction between FBXO33 and Myelocytomatosis (Myc) and its impact on Myc ubiquitination were examined. An in vivo NSCLC xenograft model was used to corroborate the in vivo experimental results.
Results
The study found an inverse correlation between FBXO33 expression in NSCLC and OS. Lower FBXO33 expression enhanced the growth, proliferation, migration, invasion, and stemness characteristics of NSCLC cell lines. FBXO33 interacted with Myc to promote its ubiquitination and subsequent degradation, which suppressed NSCLC development.
Conclusion
FBXO33 is expressed at low levels in NSCLC and correlates with lower OS. Overexpression of FBXO33 promotes Myc ubiquitination and degradation and inhibits tumor cell proliferation, migration and stemness characteristics, thereby impeding NSCLC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, 210000 Nanjing, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, Affiliated Hospital 2 of Nantong University, 226001 Nantong, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanjing Medical University, 210000 Nanjing, Jiangsu, China.
Förderung
- National Natural Science Foundation of China
- Project of Nantong Municipal Health Commission
Zitieren
APA
Wei, Q., Liu, Z., Zhu, J., Jiang, W., Xie, H., Feng, G., & Wang, K. (2024). The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2908296
Vancouver
Wei Q, Liu Z, Zhu J, Jiang W, Xie H, Feng G, et al. The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2908296
BibTeX
@article{Wei2024,
author = {Wei, Qiong and Liu, Zichun and Zhu, Jing and Jiang, Wenyan and Xie, Haiqin and Feng, Ganzhu and Wang, Keming},
title = {The Ubiquitin E3 Ligase FBXO33 Suppresses Stem Cell-Like Properties and Metastasis in Non-Small-Cell Lung Cancer by Promoting Ubiquitination and Degradation of Myc},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2908296}
}
EUVIMED